These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

698 related items for PubMed ID: 22366187

  • 1. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?
    Lecouvet FE, El Mouedden J, Collette L, Coche E, Danse E, Jamar F, Machiels JP, Vande Berg B, Omoumi P, Tombal B.
    Eur Urol; 2012 Jul; 62(1):68-75. PubMed ID: 22366187
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies.
    Lecouvet FE, Geukens D, Stainier A, Jamar F, Jamart J, d'Othée BJ, Therasse P, Vande Berg B, Tombal B.
    J Clin Oncol; 2007 Aug 01; 25(22):3281-7. PubMed ID: 17664475
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic performance of 18F-FDG PET/CT and whole-body diffusion-weighted imaging with background body suppression (DWIBS) in detection of lymph node and bone metastases from pediatric neuroblastoma.
    Ishiguchi H, Ito S, Kato K, Sakurai Y, Kawai H, Fujita N, Abe S, Narita A, Nishio N, Muramatsu H, Takahashi Y, Naganawa S.
    Ann Nucl Med; 2018 Jun 01; 32(5):348-362. PubMed ID: 29667143
    [Abstract] [Full Text] [Related]

  • 6. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
    Sakurai Y, Kawai H, Iwano S, Ito S, Ogawa H, Naganawa S.
    J Med Imaging Radiat Oncol; 2013 Jun 01; 57(3):297-305. PubMed ID: 23721138
    [Abstract] [Full Text] [Related]

  • 7. [Prostate cancer - detection of metastases: MRI or scintigraphy better?].
    Schilling D.
    Aktuelle Urol; 2013 May 01; 44(3):173-4. PubMed ID: 23712268
    [No Abstract] [Full Text] [Related]

  • 8. Whole-body MRI with diffusion-weighted sequences compared with 18 FDG PET-CT, CT and superficial lymph node ultrasonography in the staging of advanced cutaneous melanoma: a prospective study.
    Jouvet JC, Thomas L, Thomson V, Yanes M, Journe C, Morelec I, Bracoud L, Durupt F, Giammarile F, Berthezene Y.
    J Eur Acad Dermatol Venereol; 2014 Feb 01; 28(2):176-85. PubMed ID: 23331931
    [Abstract] [Full Text] [Related]

  • 9. A Prospective Comparison of 18F-prostate-specific Membrane Antigen-1007 Positron Emission Tomography Computed Tomography, Whole-body 1.5 T Magnetic Resonance Imaging with Diffusion-weighted Imaging, and Single-photon Emission Computed Tomography/Computed Tomography with Traditional Imaging in Primary Distant Metastasis Staging of Prostate Cancer (PROSTAGE).
    Anttinen M, Ettala O, Malaspina S, Jambor I, Sandell M, Kajander S, Rinta-Kiikka I, Schildt J, Saukko E, Rautio P, Timonen KL, Matikainen T, Noponen T, Saunavaara J, Löyttyniemi E, Taimen P, Kemppainen J, Dean PB, Blanco Sequeiros R, Aronen HJ, Seppänen M, Boström PJ.
    Eur Urol Oncol; 2021 Aug 01; 4(4):635-644. PubMed ID: 32675047
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL, Xue YL, Song HJ, Luo QY.
    Nucl Med Commun; 2012 Dec 01; 33(12):1232-42. PubMed ID: 23111353
    [Abstract] [Full Text] [Related]

  • 11. Multiparametric whole-body 3.0-T MRI in newly diagnosed intermediate- and high-risk prostate cancer: diagnostic accuracy and interobserver agreement for nodal and metastatic staging.
    Johnston EW, Latifoltojar A, Sidhu HS, Ramachandran N, Sokolska M, Bainbridge A, Moore C, Ahmed HU, Punwani S.
    Eur Radiol; 2019 Jun 01; 29(6):3159-3169. PubMed ID: 30519933
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Whole-body magnetic resonance imaging and prostate cancer metastases: a new gold standard of detection, but does it help us and at what cost?
    Linton KD, Catto JW.
    Eur Urol; 2012 Jul 01; 62(1):76-7. PubMed ID: 22424664
    [No Abstract] [Full Text] [Related]

  • 14. Whole-body magnetic resonance imaging for staging patients with high-risk prostate cancer.
    Fang AM, Chapin BF, Shi CW, Sun J, Qayyum A, Kundra V, Corn PG, Kuban DA, Ravizzini GC, Surasi DSS, Ma J, Bathala TK.
    Prostate Cancer Prostatic Dis; 2024 Sep 17. PubMed ID: 39289537
    [Abstract] [Full Text] [Related]

  • 15. Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases.
    Iagaru A, Young P, Mittra E, Dick DW, Herfkens R, Gambhir SS.
    Clin Nucl Med; 2013 Jul 17; 38(7):e290-6. PubMed ID: 23455520
    [Abstract] [Full Text] [Related]

  • 16. [Diagnostic value of whole-body MRI and bone scintigraphy in the detection of osseous metastases in patients with breast cancer--A Prospective Double-Blinded Study at two Hospital Centers].
    Ohlmann-Knafo S, Kirschbaum M, Fenzl G, Pickuth D.
    Rofo; 2009 Mar 17; 181(3):255-63. PubMed ID: 19229791
    [Abstract] [Full Text] [Related]

  • 17. 99mTc-HDP bone scintigraphy and 18F-sodiumfluoride PET/CT in primary staging of patients with prostate cancer.
    Wondergem M, van der Zant FM, Knol RJJ, Burgers AMG, Bos SD, de Jong IJ, Pruim J.
    World J Urol; 2018 Jan 17; 36(1):27-34. PubMed ID: 29043431
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Whole-body diffusion-weighted MRI compared with (18)F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma.
    Mosavi F, Johansson S, Sandberg DT, Turesson I, Sörensen J, Ahlström H.
    AJR Am J Roentgenol; 2012 Nov 17; 199(5):1114-20. PubMed ID: 23096187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.